| Date | Title / Description | Documents |
November 7th, 2014 |
The purpose of the “MSD for the Future State Margin Workflow” is to define recommended business and technology standards associated with implementation of the new margin rules which are scheduled to come into effect in December 2015 for certain counterparties. The document has been categorized based on five main components: 1) counterparty setup and client on-boarding, 2) trade execution, 3) initial margin (IM) & variation margin (VM) calculations, composite margin notifications & settlement provisions, 4) collateral eligibility, and 5) segregation
|
|
March 26th, 2014 |
A whitepaper discussing a Standard Initial Margin Model (SIMM) for Non-Cleared Derivatives was published by ISDA in December 2013. An appendix to the paper discussing Risk Factors and Idiosyncratic Risk was added in March 2014.
|
|
March 26th, 2014 |
A whitepaper discussing the SIMM for non-cleared derivatives was published by ISDA in December 2013. An appendix to the paper discussing risk factors and idiosyncratic risk was added in March 2014.
|
|
December 10th, 2013 |
In order to facilitate the introduction of final BCBS-IOSCO guidelines for margin requirements for non-centrally cleared derivatives, ISDA is proposing a standard initial margin model (SIMM) which could be used by market participants. A common methodology would have several key benefits to the market, such as permitting timely and transparent dispute resolution and allowing consistent regulatory governance and oversight. This whitepaper discusses the model.
|
|
April 12th, 2013 |
Letter from ISDA, IIF, AFME and SIFMA to the chairs of the BCBS, FSB, CGFS, IOSCO and CPSS (the “five chairs”) on concerns regarding the effects of initial margin (IM) requirements. The letter respectfully requests the chairs consider withdrawing or suspending any IM requirements until the consequences of such requirements have been fully analyzed and clarified.
|
|
April 12th, 2013 |
Letter from ISDA, IIF, AFME and SIFMA to the chairs of the BCBS, FSB, CGFS, IOSCO and CPSS (the “five chairs”) on concerns regarding the effects of initial margin (IM) requirements. The letter respectfully requests the chairs consider withdrawing or suspending any IM requirements until the consequences of such requirements have been fully analyzed and clarified.
|
|
April 12th, 2013 |
Letter from ISDA, IIF, AFME and SIFMA to the chairs of the BCBS, FSB, CGFS, IOSCO and CPSS (the “five chairs”) on concerns regarding the effects of initial margin (IM) requirements. The letter respectfully requests the chairs consider withdrawing or suspending any IM requirements until the consequences of such requirements have been fully analyzed and clarified.
|
|
April 12th, 2013 |
Letter from ISDA, IIF, AFME and SIFMA to the chairs of the BCBS, FSB, CGFS, IOSCO and CPSS (the “five chairs”) on concerns regarding the effects of initial margin (IM) requirements. The letter respectfully requests the chairs consider withdrawing or suspending any IM requirements until the consequences of such requirements have been fully analyzed and clarified.
|
|
November 27th, 2012 |
An analysis of initial margin (IM) requirements for non-centrally cleared OTC derivatives under current regulatory proposals. The IM analysis is based upon data submitted by member firms to the Basel Committee on Banking Supervision (BCBS) and the International Organization of Securities Commissions (IOSCO) joint Working Group on Margining Requirements (WGMR), as part of the WGMR’s Quantitative Impact Study (QIS).
|
|